logo
Plus   Neg
Share
Email

Pre-market Movers For April 11 (AA, TZOO, TITN, AAPL, NOK)

Gainers:

Alcoa, Inc. (AA) is gaining over 5 percent to $9.85. The company reported a surprise profit for its first quarter, while analysts' were expecting the company to report a loss. However, quarterly profit declined 69 percent from last year.

Travelzoo Inc. (TZOO) is jumping 29 percent to $27.29 amidst the reports that the company is preparing to sell itself.

Titan Machinery, Inc. (TITN) is gaining 18 percent to $32.55. The company's fourth quarter earnings and revenue jumped from the previous year period and were also above consensus. In addition, the company expects fiscal 2013 results above analysts' estimates.

Apple Inc. (AAPL) is gaining over 1 percent to $635.51.

Decliners:

Nokia Corp. (NOK) is sliding over 15 percent to $4.26. The company lowered its first quarter 2012 outlook for Devices & Services business, citing multiple factors that negatively affected its business to a greater extent than previously expected. The company said its Devices & Services business continues to be in the midst of transition.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT